HUMANIGEN, INC.
HGEN
HGEN was delisted on the 25th of July, 2023.
53 hedge funds and large institutions have $1.34M invested in HUMANIGEN, INC. in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 25 closing their positions.
114% more call options, than puts
Call options by funds: $47K | Put options by funds: $22K
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
18% less funds holding
Funds holding: 65 → 53 (-12)
24.03% less ownership
Funds ownership: 31.05% → 7.02% (-24%)
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
97% less capital invested
Capital invested by funds: $38.8M → $1.34M (-$37.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$466K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$427K |
| 3 |
Bank of New York Mellon
New York
|
+$323K |
| 4 |
TI
Telemetry Investments
New York
|
+$230K |
| 5 |
AMG
Advisors Management Group
La Crosse,
Wisconsin
|
+$53.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Valiant Capital Management
San Francisco,
California
|
-$12.2M |
| 2 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$9.29M |
| 3 |
CAC
Cowen and Company
New York
|
-$2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$911K |
HGEN Hedge Fund Activity: Q3 2022 in Review
53 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q3 2022, worth a combined $1.34M — down 97% from $38.8M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of HGEN and 14 opened new positions — a net loss of 11 holders — while 13 trimmed existing stakes and 13 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $466K. The largest seller was Valiant Capital Management, exiting entirely with an estimated $12.2M sold.
- 53 institutional investors held HUMANIGEN, INC. (HGEN) as of Q3 2022, down from 65 in Q2 2022.
- Funds reported $1.34M of HUMANIGEN, INC. stock for Q3 2022, down 97% quarter-over-quarter.
- 14 funds opened new HUMANIGEN, INC. positions in Q3 2022 and 25 closed out, a net change of -11 holders.
- The largest HUMANIGEN, INC. buyer in Q3 2022 was Renaissance Technologies, an estimated $466K added.
- The largest HUMANIGEN, INC. seller in Q3 2022 was Valiant Capital Management, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2022.